We are live on ! Find out more
GCTK icon

GlucoTrack
GCTK

8 hedge funds and large institutions have $248K invested in GlucoTrack in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

497% more capital invested

Capital invested by funds: $41.5K → $248K (+$206K)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

33% more funds holding

Funds holding: 6 → 8 (+2)

0.42% more ownership

Funds ownership: 0.05% → 0.47% (+0.42%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$272K
2
BFM
Boothbay Fund Management
New York
+$80.3K
3
UBS Group
UBS Group
Switzerland
+$445
4
Bank of America
Bank of America
North Carolina
+$178

Top Sellers

Rank Fund Capital Flow
1
AF
Alerus Financial
North Dakota
-$5.88K
2
Morgan Stanley
Morgan Stanley
New York
-$2.4K
3
TRCT
Tower Research Capital (TRC)
New York
-$2.31K

GCTK Hedge Fund Activity: Q4 2025 in Review

8 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q4 2025, worth a combined $248K — up 497% from $41.5K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new GCTK positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $272K. The largest seller was Alerus Financial, cutting an estimated $5.88K.

  • 8 institutional investors held GlucoTrack (GCTK) as of Q4 2025, up from 6 in Q3 2025.
  • Funds reported $248K of GlucoTrack stock for Q4 2025, up 497% quarter-over-quarter.
  • 3 funds opened new GlucoTrack positions in Q4 2025 and 1 closed out, a net change of +2 holders.
  • The largest GlucoTrack buyer in Q4 2025 was Ikarian Capital, an estimated $272K added.
  • The largest GlucoTrack seller in Q4 2025 was Alerus Financial, an estimated $5.88K sold.

Based on aggregated 13F filings for Q4 2025.